The novel treatment of tirzepatide peptide represents a significant advance in the management of the condition. Distinct from existing therapies, tirzepatide affects multiple pathways – GLP-1 and GIP – leading to https://tirzepatidepeptide707302.ssnblog.com/40643576/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment